ArchPoint Investors’s Boston Scientific BSX Stock Holding History

ArchPoint Investors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$360K	–	127
2020 Q4	$360K	Hold	10,000	–	–	0.1%	75
2020 Q3	$382K	Hold	10,000	–	–	0.12%	72
2020 Q2	$351K	Hold	10,000	–	–	0.11%	77
2020 Q1	$326K	Hold	10,000	–	–	0.13%	74
2019 Q4	$452K	Hold	10,000	–	–	0.14%	76
2019 Q3	$407K	Hold	10,000	–	–	0.14%	66
2019 Q2	$430K	Hold	10,000	–	–	0.14%	66
2019 Q1	$384K	Sell	10,000 -83,538	-89%	-$3.19M	0.11%	65
2018 Q4	$3.31M	Buy	93,538 +35	+0%	+$1.27K	1.15%	18
2018 Q3	$3.6M	Buy	93,503 +5,065	+6%	+$177K	0.98%	22
2018 Q2	$2.89M	Hold	88,438	–	–	0.83%	24
2018 Q1	$2.42M	Sell	88,438 -850	-1%	-$23.1K	0.71%	28
2017 Q4	$2.21M	Hold	89,288	–	–	0.69%	25
2017 Q3	$2.6M	Hold	89,288	–	–	0.83%	27
2017 Q2	$2.48M	Sell	89,288 -3,012	-3%	-$79.9K	0.79%	29
2017 Q1	$2.29M	Sell	92,300 -4,700	-5%	-$114K	0.86%	25
2016 Q4	$2.1M	Buy	+97,000	New	+$2.12M	1.23%	23

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

ArchPoint Investors's BSX Position: Q1 2021 in Review

ArchPoint Investors sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 10,000 shares — an estimated $360K sold.

ArchPoint Investors first reported a position in BSX in Q4 2016 and held it in 17 quarters. The position peaked at $3.6M in Q3 2018. 831 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

ArchPoint Investors reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
ArchPoint Investors sold 10,000 Boston Scientific shares in Q1 2021, an estimated $360K.
ArchPoint Investors first reported a position in Boston Scientific in Q4 2016 and held it in 17 quarters.
ArchPoint Investors's Boston Scientific position peaked at $3.6M in Q3 2018.
831 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on ArchPoint Investors's 13F filing for Q1 2021, filed 13 May 2021.